Analysis of peritoneal galactomannan for the diagnosis of Aspergillus peritonitis

Karl Dichtl1, Johannes Wagener2, Johannes Tschöp3

  • 1Max Von Pettenkofer-Institut, Ludwig-Maximilians-Universität München, 80336, Munich, Germany. dichtl@mvp.uni-muenchen.de.

Infection
|May 11, 2016
PubMed

Insights

Diagnosing intraabdominal aspergillosis can be challenging. Peritoneal fluid galactomannan testing, unlike serum testing, can aid in detecting Aspergillus fumigatus infections post-surgery.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Surgical Infections

Background:

  • Intraabdominal aspergillosis is a rare but serious invasive fungal infection.
  • Accurate and timely diagnosis is crucial for effective treatment.
  • Standard diagnostic methods may not always be sufficient.

Observation:

  • A patient developed a postoperative peritoneal infection caused by Aspergillus fumigatus.
  • Serum galactomannan levels remained negative throughout the observation period.
  • Galactomannan levels in peritoneal fluid samples were significantly elevated.

Findings:

  • Peritoneal fluid galactomannan testing demonstrated high sensitivity for diagnosing intraabdominal aspergillosis.
  • Serum galactomannan testing was insufficient for diagnosing this specific case.
  • This highlights a potential discrepancy between systemic and localized fungal markers.

Implications:

  • Serological testing of peritoneal fluid for fungal antigens is a valuable diagnostic adjunct.
  • This method may improve the early detection of invasive intraabdominal aspergillosis.
  • Easily applicable diagnostic tools are needed to support clinical decision-making in rare fungal infections.

Related Concept Videos